The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Novartis Ireland Limited naming Micheál Martin .

Filed returns
4
match these filters
Matching filed returns per period 0 0 0 0 1 May–Aug 2017: 1 filed returns Jan–Apr 2025: 1 filed returns Sep–Dec 2025: 1 filed returns May–Aug 2026: 1 filed returns 2025
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
May–Aug 2026 Novartis Ireland Limited Health Valuing Innovation & Advanced Cancer Therapy - policy and access (Public policy or programme) 27 On lobbying.ie
Sep–Dec 2025 Novartis Ireland Limited Health American Chamber of Commerce Event (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2025 Novartis Ireland Limited Health Reimbursement decision for the treatment of metastatic castration-resistant prostate cancer (mCRPC) (Matters involving public funds) 4 On lobbying.ie
May–Aug 2017 Novartis Ireland Limited Health Highlight delay in reimbursing Entresto (Heart Failure medine), the first new innovation in heart failure in a decade considered cost effective in July 2016 (Matters involving public funds) 23 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 4 100.0%